Cart
sales@molnova.com
Z-DQMD-FMK
CAS No. 767287-99-0
Z-DQMD-FMK( —— )
Catalog No. M30695 CAS No. 767287-99-0
Caspase-3 inhibitor. Inhibits MG 132-induced small cell lung cancer cell death in vitro.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameZ-DQMD-FMK
-
NoteResearch use only, not for human use.
-
Brief DescriptionCaspase-3 inhibitor. Inhibits MG 132-induced small cell lung cancer cell death in vitro.
-
DescriptionCaspase-3 inhibitor. Inhibits MG 132-induced small cell lung cancer cell death in vitro.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number767287-99-0
-
Formula Weight685.72
-
Molecular FormulaC29H40FN5O11S
-
Purity>98% (HPLC)
-
SolubilityDMSO:13.71 mg/mL
-
SMILES[H]N([C@@H](CC(=O)OC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)OC)C(=O)CF)C(=O)OCC1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Izban et al (2001) Characterization of NF-κB expression in Hodgkin's disease: inhibition of constitutively expressed NF-κB results in spontaneous caspase-independent apoptosis in Hodgkin and Reed-Sternberg cells. Mod.Pathol. 14 297 PMID:
molnova catalog
related products
-
(+)-beta-Cedrene
β-cedrene are bioactive sesquiterpenes found in cedar essential oil and exert antiseptic, anti-inflammatory, antispasmodic, tonic, astringent, diuretic, sedative, insecticidal, and antifungal activities.
-
N-Formylglycine
N-Formylglycine is a simple dipeptide and a post-translationally generated residue with unique catalytic capabilities and biotechnology applications.
-
6-Hydroxyflavanone
6-Hydroxyflavanone, a compound extracted from the leaves of Acorus calamus, exhibits anti-inflammatory and anti-neuropathic pain activity by targeting cyclooxygenase-2 (COX-2), 5-lipoxygenase (5-LOX), as well as opioid and GABA-A receptors.
